Shuzhao Chen
57 Changping Road
Shantou, 515000, China
Shantou, 515000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
VMP1 inhibits the progression of breast cancer via regulating PI3K/AKT and MEK/ERK signaling pathway.
Journal: Cancer cell international
Published: June 30, 2025
RC48-targeted two-dimensional black phosphorus nanoplatform for precise photothermal-immunotherapy of HER2-positive breast cancer.
Journal: Journal of colloid and interface science
Published: April 25, 2025
Immunometabolism signature derived from on-treatment tumor specimens predicts immune checkpoint blockade response in metastatic melanoma.
Journal: Discover oncology
Published: October 23, 2024
Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
Journal: Computational and structural biotechnology journal
Published: June 09, 2023
TSC22D3 as an immune-related prognostic biomarker for acute myeloid leukemia.
Journal: iScience
Published: April 26, 2023
A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers.
Journal: Frontiers in pharmacology
Published: March 21, 2023
A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2.
Journal: Biochemical genetics
Published: March 03, 2023
A new autophagy-related nomogram and mechanism in multiple myeloma.
Journal: Genes & diseases
Published: February 18, 2023
Functional Gene Expression Signatures from On-Treatment Tumor Specimens Predict Anti-PD1 Blockade Response in Metastatic Melanoma.
Journal: Biomolecules
Published: November 26, 2022
Comprehensive analysis of glycoprotein VI-mediated platelet activation signaling pathway for predicting pan-cancer survival and response to anti-PD-1 immunotherapy.
Journal: Computational and structural biotechnology journal
Published: October 15, 2022
Last Updated: 09/26/2026